ASH Definition of Thrombocytopenia
According to the American Society of Hematology (ASH) 2011 guidelines, thrombocytopenia in the context of immune thrombocytopenia (ITP) is defined as a platelet count less than 100 × 10⁹/L (100,000/μL). 1
Key Definitional Points
The ASH guidelines adopted the International Working Group (IWG) consensus definition, which specifically uses 100 × 10⁹/L as the threshold rather than the traditional 150 × 10⁹/L used in general hematology 1, 2, 1.
Rationale for the 100 × 10⁹/L Threshold
The IWG based this specific cutoff on three important considerations 1:
- Low progression risk: Patients presenting with platelet counts between 100-150 × 10⁹/L have only a 6.9% chance of developing persistent counts below 100 × 10⁹/L over 10 years of follow-up
- Ethnic variation: In non-Western populations, normal platelet values in healthy individuals may range between 100-150 × 10⁹/L
- Pregnancy considerations: This threshold reduces unnecessary concern over mild "physiologic" thrombocytopenia commonly associated with pregnancy
Context-Specific Definitions
It's critical to recognize that this 100 × 10⁹/L definition is specific to ITP and may not apply universally across all clinical contexts 1:
- General thrombocytopenia: Still defined as platelet count <150 × 10⁹/L in most clinical settings 3, 4, 5
- Fetal/neonatal alloimmune thrombocytopenia (FNAIT): Uses <100 × 10⁹/L at birth or within 7 days 6
- Drug-induced or acute care settings: Typically use the <150 × 10⁹/L threshold 7
Severity Classification
While defining the threshold, ASH also recognizes severity gradations for treatment decisions 1:
- Platelet counts <30 × 10⁹/L are associated with increased bleeding risk and often trigger treatment consideration
- Platelet counts <10-20 × 10⁹/L represent severe thrombocytopenia with high bleeding risk
- The specific count alone should not dictate treatment; bleeding symptoms are paramount
Important Caveats
The ASH definition requires exclusion of other causes of low platelet counts 1, 2. Primary ITP is diagnosed only when thrombocytopenia occurs "in the absence of any obvious initiating and/or underlying cause" 2. This means ruling out secondary causes such as infections (HIV, HCV, H. pylori), medications, autoimmune diseases, and lymphoproliferative disorders 1.
The definition also emphasizes that pseudothrombocytopenia must be excluded by confirming the platelet count on peripheral blood smear examination 8.